Zhenwei Jiang

Changzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Hyodeoxycholic acid ameliorates tacrolimus-induced diabetes by modulating the FXR-FGF15 axis.

Hyodeoxycholic acid ameliorates tacrolimus-induced diabetes by modulating the FXR-FGF15 axis.

Journal: Frontiers in pharmacology
Published: April 25, 2026

Metabolism of the ionizable lipid SM-102 in liver microsomes, 2D hepatocytes, and 3D liver spheroids.

Metabolism of the ionizable lipid SM-102 in liver microsomes, 2D hepatocytes, and 3D liver spheroids.

Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: February 04, 2026

Metabolomic changes associated with treatment response of neoadjuvant chemotherapy with TEC regimen in HER2-negative breast cancer.

Metabolomic changes associated with treatment response of neoadjuvant chemotherapy with TEC regimen in HER2-negative breast cancer.

Journal: Frontiers in pharmacology
Published: September 17, 2025

Indoor Localization with Extended Trajectory Map Construction and Attention Mechanisms in 5G.

Indoor Localization with Extended Trajectory Map Construction and Attention Mechanisms in 5G.

Journal: Sensors (Basel, Switzerland)
Published: August 23, 2025

Open-source liquid chromatography-mass spectrometry data processing tools for RNA modification analysis.

Open-source liquid chromatography-mass spectrometry data processing tools for RNA modification analysis.

Journal: Journal of chromatography. A
Published: June 24, 2025

Changes in the gut microbiota and derived fecal metabolites may play a role in tacrolimus-induced diabetes in mice.

Changes in the gut microbiota and derived fecal metabolites may play a role in tacrolimus-induced diabetes in mice.

Journal: Future microbiology
Published: December 23, 2024

Gut microbiota and metabolomic profile changes play critical roles in tacrolimus-induced diabetes in rats.

Gut microbiota and metabolomic profile changes play critical roles in tacrolimus-induced diabetes in rats.

Journal: Frontiers in cellular and infection microbiology
Published: May 22, 2024

Does Antibiotic Use Increase the Risk of Post-Transplantation Diabetes Mellitus? A Retrospective Study of Renal Transplant Patients.

Does Antibiotic Use Increase the Risk of Post-Transplantation Diabetes Mellitus? A Retrospective Study of Renal Transplant Patients.

Journal: Annals of transplantation
Published: April 30, 2024

Influence of UDP-Glucuronosyltransferase Polymorphisms on Mycophenolic Acid Metabolism in Renal Transplant Patients.

Influence of UDP-Glucuronosyltransferase Polymorphisms on Mycophenolic Acid Metabolism in Renal Transplant Patients.

Journal: Transplantation proceedings
Published: January 12, 2024

Determination of valproic acid and its six metabolites in human serum using LC-MS/MS and application to interaction with carbapenems in epileptic patients.

Determination of valproic acid and its six metabolites in human serum using LC-MS/MS and application to interaction with carbapenems in epileptic patients.

Journal: Biomedical chromatography : BMC
Published: August 03, 2022

Association between Genetic Polymorphisms and Risk of Kidney Posttransplant Diabetes Mellitus: A Systematic Review and Meta-Analysis.

Association between Genetic Polymorphisms and Risk of Kidney Posttransplant Diabetes Mellitus: A Systematic Review and Meta-Analysis.

Journal: International journal of clinical practice
Published: October 28, 2021

Effect of UGT polymorphisms on pharmacokinetics and adverse reactions of mycophenolic acid in kidney transplant patients.

Effect of UGT polymorphisms on pharmacokinetics and adverse reactions of mycophenolic acid in kidney transplant patients.

Journal: Pharmacogenomics
Published: September 28, 2021
Showing 1-12 of 13

Last Updated: 09/26/2026